# LOPINAVIR AND RITONAVIR
> **NDA205425** · New Drug Application · Sponsor: CIPLA LTD · Approved 2015-05-21
## Drug
- **FDA Application Number:** NDA205425
- **Application type:** New Drug Application
- **Brand name:** LOPINAVIR AND RITONAVIR
- **Generic name:** Lopinavir
- **Active ingredients:** LOPINAVIR; RITONAVIR
- **Dosage form:** PELLETS
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA LTD
- **First approval:** 2015-05-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205425)
---
*MORVS · CC0 1.0*